Continuous quality monitoring in the field: an evaluation of the performance of the Fio Deki Reader™ for rapid HIV testing in South Africa
Open Access
- 4 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 20 (1), 1-16
- https://doi.org/10.1186/s12879-020-4932-0
Abstract
Rapid diagnostic tests (RDTs) are a cornerstone of HIV diagnosis and rely on good quality processing and interpretation, particularly in the era of test and treat. The Deki Reader (Fio Corporation®, Toronto, Ontario, Canada) is a portable device designed specifically for analysing RDTs and was selected for evaluation in South Africa in the context of HIV RDT analysis. This study consisted of a laboratory evaluation and two-part field evaluation of the Deki Reader v100, covering two RDT testing algorithms, and an evaluation of the continuous quality monitoring through the Fionet™ web portal. Based on user feedback from the field evaluation, the device underwent hardware and software redesign, and the Deki Reader v200 was evaluated in the laboratory. Ethics approval for this evaluation was obtained from the University of the Witwatersrand Human Research Ethics Committee: M150160. The intra- and inter-device laboratory precision of the Deki Reader v100 were 98.3 and 99.2% respectively, and 99.3 and 100% for the Deki Reader v200. The laboratory concordances compared to standard-of-care reporting were 99.5 and 98.0% for the two respective models, while sensitivity and specificity were 99.5 and 99.4% for the Deki Reader V100 and 100 and 93.1% for the Deki Reader V200 respectively. Screening and confirmatory concordances in the field were 99.3 and 96.5% under algorithm 1 and 99.7 and 100% under algorithm 2. Sensitivity and specificity for the field evaluation were 99.8 and 97.7%. Overall robustness of the device was acceptable and continuous quality monitoring through Fionet™ was feasible. The Deki Reader provides an option for improved and reliable quality assessment for rapid diagnosis of HIV using RDTs to enhance the quality of healthcare at the point-of-care. However, the introduction of new RDTs and modification of current algorithms necessitates ongoing and agile RDT reader adjustments, which will require cost modelling to ensure sustainability of devices implemented into national HIV programs.Funding Information
- South African Medical Research Council (#015NEWTON TB)
- Global Fund to Fight AIDS, Tuberculosis and Malaria (ZAC-C-NDOH)
- Bill and Melinda Gates Foundation (OPP1171455)
This publication has 26 references indexed in Scilit:
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV InfectionThe New England Journal of Medicine, 2015
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in AfricaThe New England Journal of Medicine, 2015
- Using electronic readers to monitor progress toward elimination of mother-to-child transmission of HIV and syphilis: An opinion pieceInternational Journal of Gynecology & Obstetrics, 2015
- Field evaluation of an automated RDT reader and data management device for Plasmodium falciparum/Plasmodium vivax malaria in endemic areas of ColombiaMalaria Journal, 2014
- Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialThe Lancet Infectious Diseases, 2014
- Clinical performance of an automated reader in interpreting malaria rapid diagnostic tests in TanzaniaMalaria Journal, 2013
- Integrated rapid-diagnostic-test reader platform on a cellphoneLab on a Chip, 2012
- Scaling Up HIV Rapid Testing in Developing CountriesAmerican Journal of Clinical Pathology, 2010
- Dried tube specimens: A simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settingsJournal of Virological Methods, 2010
- Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy studyBMJ, 2007